GOBIVAZ

Medicinal product

(Invented) name

GOBIVAZ

Active substance (s)

Golimumabas

Strength

100 mg

Pharmaceutical form

injekcinis tirpalas užpildytame švirkšte

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AB06, Golimumab

Marketing authorisation holder

Advanz Pharma Limited, Airija

Date of authorisation

2025-11-17

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(4)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Užpildytame švirkšte (1 ml tirpalo) yra	1 ml
Golimumabas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119184	105288	1105288	užpildytas švirkštas	N1		Receptinis	EU/1/25/1988/007	Netiekiama	-	-	No	-	-
119185	105289	1105289	užpildytas švirkštas	N3 (3×1)		Receptinis	EU/1/25/1988/008	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-11-17	Registruotas